Tristel plc Overview
Pro stress-test →Tristel plc is a manufacturer of infection prevention products for hospitals, specializing in chlorine dioxide chemistry used for the decontamination of medical devices and sporicidal disinfection of environmental surfaces. The company serves a critical healthcare market segment with proprietary technology and operates globally across 40+ countries.
Strategic Profile
Pro stress-test →Tristel's strategy is to sustain double-digit growth and deliver long-term value by extending leadership in point-of-care medical device disinfection and sporicidal surface disinfection. Operating from Snailwell near Cambridge with approximately 270 employees across 16 subsidiaries, the company maintains a debt-free balance sheet and targets EBITDA margins of at least 25%.
Competitive Landscape
Pro stress-test →Tristel's core competitive advantage lies in proprietary chlorine dioxide chemistry domain knowledge with R&D focused on microbial efficacy improvements and manufacturing efficiency. The company operates in the hospital infection control market where regulatory barriers and clinical validation create switching costs. Primary competitors include larger medical device manufacturers and regional disinfection product providers.
Industry Context
Tristel plc operates in Healthcare - Infection Control/Hospital Disinfection Products.
Key facts
Founded: 1993 · Headquarters: Snailwell, United Kingdom · Employees: 270 · Revenue: $55.7M · Market cap: $207M